These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 1720904

  • 1. Limited proteolysis of vitronectin by plasmin destroys heparin binding activity.
    Sane DC, Moser TL, Greenberg CS.
    Thromb Haemost; 1991 Sep 02; 66(3):310-4. PubMed ID: 1720904
    [Abstract] [Full Text] [Related]

  • 2. Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation.
    Kost C, Stüber W, Ehrlich HJ, Pannekoek H, Preissner KT.
    J Biol Chem; 1992 Jun 15; 267(17):12098-105. PubMed ID: 1376317
    [Abstract] [Full Text] [Related]

  • 3. Vitronectin modulates glycosaminoglycan dependent reactions of protein C inhibitor.
    Seiffert D, Geiger M, Ecke S, Binder BR.
    Thromb Haemost; 1992 Dec 07; 68(6):657-61. PubMed ID: 1283793
    [Abstract] [Full Text] [Related]

  • 4. Regulation of histidine-rich glycoprotein (HRG) function via plasmin-mediated proteolytic cleavage.
    Poon IK, Olsson AK, Hulett MD, Parish CR.
    Biochem J; 2009 Oct 23; 424(1):27-37. PubMed ID: 19712047
    [Abstract] [Full Text] [Related]

  • 5. Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin (Vn): mapping the binding sites on PAI-1 and Vn.
    Schroeck F, Arroyo de Prada N, Sperl S, Schmitt M, Viktor M.
    Biol Chem; 2002 Oct 23; 383(7-8):1143-9. PubMed ID: 12437099
    [Abstract] [Full Text] [Related]

  • 6. The urokinase receptor is a major vitronectin-binding protein on endothelial cells.
    Kanse SM, Kost C, Wilhelm OG, Andreasen PA, Preissner KT.
    Exp Cell Res; 1996 May 01; 224(2):344-53. PubMed ID: 8612711
    [Abstract] [Full Text] [Related]

  • 7. Highly sulfated glycosaminoglycans augment the cross-linking of vitronectin by guinea pig liver transglutaminase. Functional studies of the cross-linked vitronectin multimers.
    Sane DC, Moser TL, Parker CJ, Seiffert D, Loskutoff DJ, Greenberg CS.
    J Biol Chem; 1990 Feb 25; 265(6):3543-8. PubMed ID: 1689304
    [Abstract] [Full Text] [Related]

  • 8. Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1.
    Whitley BR, Church FC.
    Int J Oncol; 2005 Sep 25; 27(3):749-57. PubMed ID: 16077925
    [Abstract] [Full Text] [Related]

  • 9. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
    Lind SE, Smith CJ.
    Arch Biochem Biophys; 1993 Nov 15; 307(1):138-45. PubMed ID: 8239651
    [Abstract] [Full Text] [Related]

  • 10. The composition of complexes between plasminogen activator inhibitor 1, vitronectin and either thrombin or tissue-type plasminogen activator.
    van Meijer M, Stoop A, Smilde A, Preissner KT, van Zonneveld AJ, Pannekoek H.
    Thromb Haemost; 1997 Mar 15; 77(3):516-21. PubMed ID: 9066004
    [Abstract] [Full Text] [Related]

  • 11. Specific binding of plasminogen to vitronectin. Evidence for a modulatory role of vitronectin on fibrin(ogen)-induced plasmin formation by tissue plasminogen activator.
    Preissner KT.
    Biochem Biophys Res Commun; 1990 May 16; 168(3):966-71. PubMed ID: 1693270
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression of a recombinant baculovirus for vitronectin in insect cells: purification, characterization of post-translational modifications and functional studies of the recombinant protein.
    Zhao Y, Sane DC.
    Arch Biochem Biophys; 1993 Aug 01; 304(2):434-42. PubMed ID: 7688496
    [Abstract] [Full Text] [Related]

  • 14. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.
    Liotta LA, Goldfarb RH, Brundage R, Siegal GP, Terranova V, Garbisa S.
    Cancer Res; 1981 Nov 01; 41(11 Pt 1):4629-36. PubMed ID: 6458354
    [Abstract] [Full Text] [Related]

  • 15. Plasmin-induced proteolysis of tenascin-C: modulation by T lymphocyte-derived urokinase-type plasminogen activator and effect on T lymphocyte adhesion, activation, and cell clustering.
    Gundersen D, Trân-Thang C, Sordat B, Mourali F, Rüegg C.
    J Immunol; 1997 Feb 01; 158(3):1051-60. PubMed ID: 9013942
    [Abstract] [Full Text] [Related]

  • 16. Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin.
    Preissner KT, Grulich-Henn J, Ehrlich HJ, Declerck P, Justus C, Collen D, Pannekoek H, Müller-Berghaus G.
    J Biol Chem; 1990 Oct 25; 265(30):18490-8. PubMed ID: 1698787
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Binding of one-chain tissue-type plasminogen activator to fibrin, partially plasmin-degraded fibrin, lysine and heparin.
    Fischer B.
    Biomed Biochim Acta; 1991 Oct 25; 50(1):47-54. PubMed ID: 1830477
    [Abstract] [Full Text] [Related]

  • 19. Less pronounced enhancement of thrombin-dependent inactivation of plasminogen activator inhibitor type 1 by low molecular weight heparin compared with unfractionated heparin.
    Nakamura R, Umemura K, Hashimmoto H, Urano T.
    Thromb Haemost; 2006 Apr 25; 95(4):637-42. PubMed ID: 16601834
    [Abstract] [Full Text] [Related]

  • 20. Localization of a vitronectin binding region of plasminogen activator inhibitor-1.
    Padmanabhan J, Sane DC.
    Thromb Haemost; 1995 May 25; 73(5):829-34. PubMed ID: 7482411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.